AU5284000A - Inhibitors of factor xa - Google Patents
Inhibitors of factor xaInfo
- Publication number
- AU5284000A AU5284000A AU52840/00A AU5284000A AU5284000A AU 5284000 A AU5284000 A AU 5284000A AU 52840/00 A AU52840/00 A AU 52840/00A AU 5284000 A AU5284000 A AU 5284000A AU 5284000 A AU5284000 A AU 5284000A
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13583899P | 1999-05-24 | 1999-05-24 | |
| US60135838 | 1999-05-24 | ||
| PCT/US2000/014209 WO2000071516A2 (en) | 1999-05-24 | 2000-05-24 | INHIBITORS OF FACTOR Xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5284000A true AU5284000A (en) | 2000-12-12 |
Family
ID=22469944
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU52836/00A Abandoned AU5283600A (en) | 1999-05-24 | 2000-05-24 | Inhibitors of factor xa |
| AU52840/00A Abandoned AU5284000A (en) | 1999-05-24 | 2000-05-24 | Inhibitors of factor xa |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU52836/00A Abandoned AU5283600A (en) | 1999-05-24 | 2000-05-24 | Inhibitors of factor xa |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1185511A2 (en) |
| JP (2) | JP2003500391A (en) |
| AU (2) | AU5283600A (en) |
| CA (2) | CA2371904A1 (en) |
| WO (2) | WO2000071515A2 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999047503A1 (en) | 1998-03-19 | 1999-09-23 | Ajinomoto Co., Inc. | Aminoisoquinoline derivatives |
| TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
| DE10139060A1 (en) | 2001-08-08 | 2003-02-20 | Merck Patent Gmbh | New bicyclic benzene derivatives useful as factor Xa and VIIa inhibitors, e.g. for treating thrombosis, myocardial infarct, arteriosclerosis, inflammation, stroke, angina, restenosis and tumors |
| EP1485353B1 (en) | 2002-03-13 | 2011-08-24 | Janssen Pharmaceutica NV | New inhibitors of histone deacetylase |
| KR20040093692A (en) | 2002-03-13 | 2004-11-08 | 얀센 파마슈티카 엔.브이. | Piperazinyl-, piperidynyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| NZ534831A (en) | 2002-03-13 | 2007-01-26 | Janssen Pharmaceutica Nv | Carbonylamino-derivatives having histone deacetylase (HDAC) inhibiting enzymatic activity |
| PE20040167A1 (en) | 2002-03-28 | 2004-05-26 | Novartis Ag | SULPHAMIC ACID AMIDES |
| EP2982668A3 (en) | 2002-12-03 | 2016-04-13 | Pharmacyclics LLC | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders |
| ATE430139T1 (en) | 2003-04-03 | 2009-05-15 | Merck Patent Gmbh | PYRROLIDINE-1,2-DICARBONONIC ACID-1-(PHENYLAMIDE)-2-( - (3-OXO-MORPHOLINE-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF COAGULATION FACTOR XA FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES |
| CA2532965C (en) | 2003-07-22 | 2013-05-14 | Astex Therapeutics Limited | 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| DE102004014945A1 (en) * | 2004-03-26 | 2005-10-13 | Merck Patent Gmbh | Prolinylderivate |
| PL1781639T3 (en) | 2004-07-28 | 2012-07-31 | Janssen Pharmaceutica Nv | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
| AR054425A1 (en) | 2005-01-21 | 2007-06-27 | Astex Therapeutics Ltd | PIPERIDIN ADDITION SALTS 4-IL-ACID AMID 4- (2,6-DICLORO-BENZOILAMINO) 1H-PIRAZOL-3-CARBOXILICO. |
| JP5247470B2 (en) | 2006-01-19 | 2013-07-24 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| EP3541381B1 (en) * | 2016-11-18 | 2022-12-28 | Merck Sharp & Dohme LLC | Inhibitors of factor xiia |
| CN118903436A (en) | 2018-01-31 | 2024-11-08 | 德西费拉制药有限责任公司 | Combination therapy for the treatment of mastocytosis |
| AU2019215081B2 (en) | 2018-01-31 | 2024-07-25 | Deciphera Pharmaceuticals, Llc. | Combination therapy for the treatment of gastrointestinal stromal tumors |
| TW202122082A (en) | 2019-08-12 | 2021-06-16 | 美商迪賽孚爾製藥有限公司 | Methods of treating gastrointestinal stromal tumors |
| CN114615982A (en) | 2019-08-12 | 2022-06-10 | 德西费拉制药有限责任公司 | Ripoctinib for treating gastrointestinal stromal tumor |
| KR20220123057A (en) | 2019-12-30 | 2022-09-05 | 데시페라 파마슈티칼스, 엘엘씨. | Amorphous kinase inhibitor formulations and methods of use thereof |
| DK4084779T3 (en) | 2019-12-30 | 2024-12-16 | Deciphera Pharmaceuticals Llc | COMPOSITIONS OF 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO- 1,6-NAPHTHYRIDIN-3-YL)-2-FLUORPHENYL)-3-PHENYLUREA |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2262117A1 (en) * | 1996-08-16 | 1998-02-19 | The Dupont Merck Pharmaceutical Company | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| PL334250A1 (en) * | 1996-12-23 | 2000-02-14 | Du Pont Pharm Co | Nitrogen containing hetero-aromatic compounds and inhibitors of xa factor |
-
2000
- 2000-05-24 WO PCT/US2000/014193 patent/WO2000071515A2/en not_active Application Discontinuation
- 2000-05-24 AU AU52836/00A patent/AU5283600A/en not_active Abandoned
- 2000-05-24 JP JP2000619773A patent/JP2003500391A/en active Pending
- 2000-05-24 EP EP00937698A patent/EP1185511A2/en not_active Withdrawn
- 2000-05-24 EP EP00937704A patent/EP1185512A2/en not_active Withdrawn
- 2000-05-24 CA CA002371904A patent/CA2371904A1/en not_active Abandoned
- 2000-05-24 AU AU52840/00A patent/AU5284000A/en not_active Abandoned
- 2000-05-24 WO PCT/US2000/014209 patent/WO2000071516A2/en not_active Application Discontinuation
- 2000-05-24 JP JP2000619772A patent/JP2003500390A/en active Pending
- 2000-05-24 CA CA002374788A patent/CA2374788A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2371904A1 (en) | 2000-11-30 |
| WO2000071515A2 (en) | 2000-11-30 |
| AU5283600A (en) | 2000-12-12 |
| CA2374788A1 (en) | 2000-11-30 |
| EP1185512A2 (en) | 2002-03-13 |
| JP2003500390A (en) | 2003-01-07 |
| WO2000071516B1 (en) | 2001-03-01 |
| WO2000071515A3 (en) | 2001-01-25 |
| JP2003500391A (en) | 2003-01-07 |
| EP1185511A2 (en) | 2002-03-13 |
| WO2000071516A3 (en) | 2001-01-18 |
| WO2000071516A2 (en) | 2000-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6762400A (en) | Inhibitors of factor xa | |
| AU5723500A (en) | Inhibitors of factor xa | |
| AU5158100A (en) | Inhibitors of factor xa | |
| AU5155500A (en) | Inhibitors of factor xa | |
| AU3857300A (en) | Inhibitors of factor xa | |
| IL148698A0 (en) | INHIBITORS OF FACTOR Xa | |
| AU5283600A (en) | Inhibitors of factor xa | |
| AU2001273040A1 (en) | Factor xa inhibitors | |
| AU2001249399A1 (en) | Isoquinolone inhibitors of factor xa | |
| AU2002350217A1 (en) | Glycinamides as factor xa inhibitors | |
| PL342243A1 (en) | Substituted oxoazaheterocyclic inhibitors of the factor xa | |
| PL339173A1 (en) | Derivatives of benzamidine as inhibitors of factor xa | |
| AU4343500A (en) | Use of azetidinone compounds | |
| AU2381600A (en) | Thrombin or factor xa inhibitors | |
| AU2001234705A1 (en) | Indalone and benzimidazolone inhibitors of factor xa | |
| AU6111000A (en) | Inhibitors of viral helcase | |
| AU2002365896A1 (en) | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | |
| AU5619400A (en) | Statine-derived tetrapeptide inhibitors of beta-secretase | |
| AU2001249397A1 (en) | Oxindole inhibitors of factor xa | |
| AU2001297648A1 (en) | Substituted carboxamides as inhibitors of factor xa | |
| AU2001294824A1 (en) | Piperazine based inhibitors of factor xa | |
| PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
| AU3235100A (en) | Prothease inhibitors | |
| AU2002222933A1 (en) | Inhibitors of factor xa | |
| AU2002211281A1 (en) | Quaternary amidino based inhibitors of factor xa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |